|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,323.95 INR | -0.38% |
|
+9.57% | -5.79% |
| Market Cap | 395B 4.19B 3.65B 3.38B 3.17B 5.94B 5.97B 40.12B 15.55B 195B 15.72B 15.38B 675B | P/E 2027 * |
34.7x | P/E 2028 * | 30.7x |
|---|---|---|---|---|---|
| Enterprise Value | 395B 4.19B 3.65B 3.38B 3.17B 5.94B 5.97B 40.12B 15.55B 195B 15.72B 15.38B 675B | EV / Sales 2027 * |
9.42x | EV / Sales 2028 * | 8.51x |
| Free-Float |
24.36% | Yield 2027 * |
1.26% | Yield 2028 * | 1.26% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -0.21% | ||
| 1 week | +9.57% | ||
| Current month | +5.40% | ||
| 1 month | +0.79% | ||
| 3 months | +2.11% | ||
| 6 months | -7.74% | ||
| Current year | -5.79% |
| 1 week | 2,126.8 |  | 2,371.3 |
| 1 month | 2,088 | | 2,371.3 |
| Current year | 2,088 | | 2,715.15 |
| 1 year | 2,088 | | 3,500 |
| 3 years | 1,376.5 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 30/11/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 31/03/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 07/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 06/04/2017 |
Renu Sud Karnad
CHM | Chairman | 73 | 31/03/2019 |
| Director/Board Member | 59 | 17/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.38% | +9.57% | -26.55% | +62.10% | 4.19B | |
| -1.21% | -3.04% | +44.03% | +142.51% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.36% | 550B | |
| -2.14% | -4.94% | +16.83% | +58.18% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.78% | 316B | |
| +0.61% | -1.69% | +27.35% | +14.22% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.69% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.41% | 199B | |
| -1.19% | -4.95% | +16.68% | +48.70% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.46% | 154B | |
| Average | -0.29% | -1.43% | +15.45% | +42.56% | 330.65B | |
| Weighted average by Cap. | -0.78% | -3.49% | +29.42% | +63.49% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.94B 444M 388M 359M 336M 630M 634M 4.26B 1.65B 20.64B 1.67B 1.63B 71.68B | 46.45B 492M 429M 398M 372M 698M 702M 4.72B 1.83B 22.86B 1.85B 1.81B 79.39B |
| Net income | 11.4B 121M 105M 97.58M 91.34M 171M 172M 1.16B 449M 5.61B 454M 444M 19.49B | 12.87B 136M 119M 110M 103M 193M 195M 1.31B 507M 6.34B 512M 501M 22B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/06/26 | 2,323.95 ₹ | -0.38% | 6,995 |
| 19/06/26 | 2,332.85 ₹ | +2.91% | 26,977 |
| 18/06/26 | 2,266.85 ₹ | +3.09% | 57,756 |
| 17/06/26 | 2,198.85 ₹ | -0.10% | 8,187 |
| 16/06/26 | 2,201.15 ₹ | +3.60% | 29,606 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
